Targeted Disruption of FANCC and FANCG in Human Cancer Provides a Preclinical Model for Specific Therapeutic Options
- 30 June 2006
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 130 (7), 2145-2154
- https://doi.org/10.1053/j.gastro.2006.03.016
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- The Fanconi Anemia/BRCA pathway: new faces in the crowdGenes & Development, 2005
- A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group MNature Genetics, 2005
- New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutantDNA Repair, 2005
- Functional Defects in the Fanconi Anemia Pathway in Pancreatic Cancer CellsThe American Journal of Pathology, 2004
- Oxidant Hypersensitivity of Fanconi Anemia Type C-deficient Cells Is Dependent on a Redox-regulated Apoptotic PathwayPublished by Elsevier BV ,2004
- Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypesBlood, 2004
- Lack of Sensitivity of Primary Fanconi's Anemia Fibroblasts to UV and Ionizing RadiationRadiation Research, 2004
- The Fanconi anaemia/BRCA pathwayNature Reviews Cancer, 2003
- The Chinese hamster V79 cell mutant V-H4 is phenotypically like Fanconi anemia cellsSomatic Cell and Molecular Genetics, 1990
- Effect of oxidants and antioxidants on chromosomal breakage in Fanconi anemia lymphocytesHuman Genetics, 1985